FDA Inspection 981282 — MPP PHARMA LLC
The FDA completed an inspection of MPP PHARMA LLC on Apr 4, 2016 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 4, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kansas City, MO (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)